- Home
- XXII vs PTPI Comparison
XXII vs PTPI Comparison
Compare XXII & PTPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XXII
- PTPI
- Stock Information
- Founded
- XXII 1998
- PTPI 2020
- Country
- XXII United States
- PTPI United States
- Employees
- XXII N/A
- PTPI N/A
- Industry
- XXII Medicinal Chemicals and Botanical Products
- PTPI Biotechnology: Pharmaceutical Preparations
- Sector
- XXII Health Care
- PTPI Health Care
- Exchange
- XXII Nasdaq
- PTPI Nasdaq
- Market Cap
- XXII 2.1M
- PTPI 2.2M
- IPO Year
- XXII N/A
- PTPI N/A
- Fundamental
- Price
- XXII $1.08
- PTPI $0.13
- Analyst Decision
- XXII
- PTPI
- Analyst Count
- XXII 0
- PTPI 0
- Target Price
- XXII N/A
- PTPI N/A
- AVG Volume (30 Days)
- XXII 603.9K
- PTPI 16.9M
- Earning Date
- XXII 05-13-2025
- PTPI 05-27-2025
- Dividend Yield
- XXII N/A
- PTPI N/A
- EPS Growth
- XXII N/A
- PTPI N/A
- EPS
- XXII N/A
- PTPI N/A
- Revenue
- XXII $23,869,000.00
- PTPI $5,112,043.00
- Revenue This Year
- XXII $19.23
- PTPI $9.25
- Revenue Next Year
- XXII $81.05
- PTPI N/A
- P/E Ratio
- XXII N/A
- PTPI N/A
- Revenue Growth
- XXII N/A
- PTPI 54.70
- 52 Week Low
- XXII $0.70
- PTPI $0.12
- 52 Week High
- XXII $226.80
- PTPI $18.00
- Technical
- Relative Strength Index (RSI)
- XXII 47.15
- PTPI 28.96
- Support Level
- XXII $1.06
- PTPI $0.10
- Resistance Level
- XXII $1.26
- PTPI $0.20
- Average True Range (ATR)
- XXII 0.17
- PTPI 0.10
- MACD
- XXII 0.04
- PTPI 0.04
- Stochastic Oscillator
- XXII 49.25
- PTPI 3.57
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.
About PTPI Petros Pharmaceuticals Inc.
Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on therapeutics that promote medication adherence, tolerability, and preservation of male organic function. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Medical Devices segment. The Prescription Medications segment consists of operations related to vacuum erection devices, which are sold domestically and internationally.